osudhkosh
New
Company•Renata Limited

U (10)

25mcg+62.5mcg+100mcgRx
Generic: Vilanterol Trifenatate + Fluticasone Furoate + Umeclidinium Bromide

৳ 90/unit

Pack: ৳ 900

CapsuleBox (10 Capsule)
Save to my medicines
Alert me on price drop

At a glance

Vilanterol Trifenatate + Fluticasone Furoate + Umeclidinium Bromide is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD) and the maintenance treatment of asthma in patients aged 18 years and older.

Indications
  • Chronic obstructive pulmonary disease (COPD)
  • Asthma (18 years and older)
Pharmacology

This capsule is an inhalation powder drug product. Vilanterol is a LABA that stimulates intracellular adenyl cyclase, increasing cyclic AMP, which relaxes bronchial smooth muscle. Fluticasone furoate is an ICS with a wide range of actions on multiple cell types and mediators involved in inflammation. Umeclidinium is a LAMA that inhibits M3 receptor, leading to bronchodilation.

Dosage

Adult Dose (Inhalation):

  • COPD maintenance: 1 inhalation capsule once daily
  • Asthma maintenance: 1 inhalation capsule once daily
  • Use at the same time every day, not more than once every 24 hours
Side effects

Common Side Effects:

  • Upper respiratory tract infection
  • Pneumonia
  • Bronchitis
  • Oral candidiasis
  • Headache
  • Back pain
  • Arthralgia
  • Influenza
  • Sinusitis
  • Pharyngitis
  • Rhinitis
  • Dysgeusia
  • Constipation
  • Urinary tract infection
  • Diarrhea
  • Gastroenteritis
  • Oropharyngeal pain
  • Cough
  • Dysphonia
Use in pregnancy

Use in Pregnancy: Insufficient data on use in pregnant women.

Pregnancy Category: C — always consult a doctor before taking during pregnancy.

Precautions & warnings
  • LABA monotherapy increases risk of serious asthma-related events
  • Do not initiate in acutely deteriorating COPD or asthma
  • Do not use to treat acute symptoms
  • Do not use in combination with additional LABA-containing therapy
  • Candida albicans infection of mouth and pharynx may occur; monitor periodically
  • Increased risk of pneumonia in patients with COPD; monitor for signs and symptoms
  • If paradoxical bronchospasm occurs, discontinue and institute alternative therapy
  • Use with caution in patients with cardiovascular disorders
  • Worsening of urinary retention may occur; caution in prostatic hyperplasia or bladder-neck obstruction
  • Use with caution in patients with convulsive disorders, thyrotoxicosis, diabetes mellitus, and ketoacidosis
Overdose effects

Symptoms: No data available from clinical trials on overdose.

Treatment: Supportive care.

Storage conditions

Avoid storage in direct sunlight or heat. Store in a cool & dry place. Keep away from eyes. Keep out of reach of children.

Vilanterol Trifenatate + Fluticasone Furoate + Umeclidinium Bromide — see the full informationPharmacology, precautions, pregnancy, overdose and the rest on the generic page
⚠️ This information is for educational purposes only — not a substitute for medical advice. Consult a registered physician before taking any medicine.